TipRanks
Linea Directa Aseguradora SA (MX:LDAN)
:LDAN
Mexico Market
EarningsQ2 2026 Earnings Report

Linea Directa Aseguradora SA (LDAN) Q2 2026 Earnings Report

0 Followers

MX:LDAN Q2 2026 EPS Results

Actual EPS$0.51
Consensus EPS$0.47
Beat/MissBeat by +$0.04
One Year Ago EPS$0.82

MX:LDAN Q2 2026 Revenue Results

Actual Revenue$12.28B
Expected Revenue$6.15B
Beat/MissBeat by +$6.13B
YoY Revenue Growth+10.63%

Earnings Announcement Details

QuarterQ2 2026
Date07/27/2026
TimeBefore Open
Conference CallMonday, July 27, 2026
MX:LDAN Upcoming Earnings
Linea Directa Aseguradora SA's next earnings date is estimated for October 16, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Jul 27, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed a predominantly positive operating and capital story: double‑digit increases in net profit, strong premium growth across lines, improved combined ratios and a fortified Solvency II ratio (196.3%). Efficiency gains, higher digital sales and a resilient Motor franchise underpin the upbeat tone. Key risks flagged include a still loss‑making Health line (combined ratio 125.1%), a temporary hit to investment income from a real estate renovation (net investment result ‑1.8%), slower average premium increases (~2%) amid inflationary monitoring, and sensitivity to atmospheric/seasonal events. On balance, the positive growth, margin improvement and very strong solvency position outweigh the noted challenges.
Company Guidance
Management's guidance emphasized three clear priorities—maintain profitability growth, protect technical margins and keep leveraging efficiency—while promising active monitoring and price adjustments if inflation pressures increase (current average premium upside ~2% on new business). They signposted continued shareholder distributions (two interim payments during the year plus a complementary year‑end payment, final payout subject to the Board), and digital sales momentum (~13–14% of new production). Key metrics they said they will defend include: H1 gross written premiums €609.3m (+9.2% YoY), customer portfolio +7.8% (~+278k risks YoY; ~+60k in Q2), combined ratio 91.1% H1 (expense ratio 20.2%), net profit €52.1m (+19%), ROE 23.3% and Solvency II 196.3% (after the interim dividend); line highlights to protect were Motor premiums >€490m (+9.8%) with motor combined ratio 91.1% H1, Home combined ratio 86.6% H1, Health premiums €28.9m (+17.7%) with combined ratio 125.1% improving 8.6pp, investment return 275bps (fixed‑income duration 3.5y) and reported net investment result -1.8% (≈+5% excl. a real‑estate one‑off).
Strong Premium Growth and Portfolio Expansion
Gross written premiums reached EUR 609.3 million, up 9.2% year‑on‑year. The customer portfolio increased to 3.86 million risks, +7.8% year‑on‑year, with close to 278,000 risks added over the last 12 months (around 60,000 added in Q2).
Improved Profitability and Return on Equity
Net profit rose 19% year‑on‑year to EUR 52.1 million. Return on equity stood at 23.3%, supported by higher volumes, better underwriting performance and efficiency gains.
Underwriting Discipline — Better Combined Ratio
Group combined ratio improved to 91.1% (1.2 percentage points better year‑on‑year). Management highlights continued quarter‑on‑quarter improvement in technical margins and a favorable stand‑alone Q2 underwriting performance.
Motor Segment Growth and Profitability
Motor premiums exceeded EUR 490 million, up 9.8% year‑on‑year. The portfolio added over 222,000 policies in the last 12 months (59,000 in Q2). Motor combined ratio for H1 was 91.1% (0.9 pp better year‑on‑year).
Home Line Strong Technical Performance
Home premiums grew 2% with the portfolio up 3.7% year‑on‑year. Home combined ratio improved to 86.6% in H1 (improving 2.3 pp) and was 83.9% in stand‑alone Q2, reflecting limited atmospheric events and improved risk profiling.
Health Commercial Momentum and Product Mix Shift
Health premiums increased 17.7% to EUR 28.9 million; the health portfolio surpassed 128,000 policies (+10.4% year‑on‑year). Management is shifting toward more comprehensive and specialty products, now ~68% of the health book.
Strong Capital and Solvency Position
Solvency II ratio strengthened to 196.3% at end‑June, driven by organic capital generation and positive revaluation of the investment portfolio. Management indicates an approximate +400 basis point solvency impact from unrealized gains (unrealized gains ~EUR 10 million in the quarter).
Improving Expense Efficiency and Digital Sales
Group expense ratio improved to 20.2% reflecting scale benefits and operating discipline. Digital (fully self‑service) sales accelerated from ~9% previously to roughly 13–14% of new production, supporting efficiency and customer experience.
Investment Portfolio Performance
Investment portfolio delivered a return of 275 basis points; investment result (fixed income and equities) improved with the stated investment result reaching EUR 21.8 million and investment income up ~5.2% (excluding one‑off real estate impact).

MX:LDAN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Oct 16, 2026
2026 (Q3)
0.47 / -
0.307―
2026 (Q2)
0.47 / 0.51
0.82-37.50% (-0.31)
2026 (Q1)
0.45 / 0.45
0.738-38.89% (-0.29)
2025 (Q4)
0.41 / 0.49
0.738-33.33% (-0.25)
2025 (Q3)
0.43 / 0.31
0.471-34.78% (-0.16)
2025 (Q2)
0.43 / 0.82
0.47173.91% (+0.35)
Apr 18, 2025
2025 (Q1)
0.35 / -
0.205―
2024 (Q4)
- / 0.74
0.205260.00% (+0.53)
2024 (Q3)
- / -
-0.287―
Jul 24, 2024
2024 (Q2)
- / 0.47
-0.287264.29% (+0.76)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed